Indian Pharma Stocks Surge on US Price Order

  Published 1 year ago

Indian pharmaceutical stocks rallied after the US HHS announced it expects branded drugmakers to align US prices with peer nations. Analysts believe this benefits generic and biosimilar companies, reversing a previous dip caused by Trump's price-cut order.

  • NIPHARM index climbed 1.7%, leading sectors.
  • Gland Pharma jumped 4%, leading stock gains.
  • Generic/biosimilar firms see 'big relief'.

You might like these

Maruti Suzuki August 2025 Sales

United Breweries Q1 Sales Jump 16%

EPFO Passbook Lite and Faster Services

L&T Bags Rs 1,000, Crore Bhavali PSP Order in Maharashtra

Tiger Securities Expands in Hong Kong

Borosil Posts Loss, Plans Fundraise

Aurigene's 2025 Financial Highlights: Profit, Cash Flow, EPS

News that matters the most ⚡